Andrew J. Last
Net Worth
Last updated:
What is Andrew J. Last net worth?
The estimated net worth of Dr. Andrew J. Last is at least $18,987,577 as of 29 Apr 2023. He owns shares worth $734,897 as insider, has earned $3,252,680 from insider trading and has received compensation worth at least $15,000,000 in Bio-Rad Laboratories, Inc. and Bio-Rad Laboratories, Inc..
What is the salary of Andrew J. Last?
Dr. Andrew J. Last salary is $1,500,000 per year as Executive Vice President & Chief Operating Officer in Bio-Rad Laboratories, Inc.. He also receives $1,500,000 as Executive Vice President & Chief Operating Officer in Bio-Rad Laboratories, Inc..
How old is Andrew J. Last?
Dr. Andrew J. Last is 65 years old, born in 1960.
What stocks does Andrew J. Last currently own?
As insider, Dr. Andrew J. Last owns shares in 2 companies:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Bio-Rad Laboratories, Inc. (BIO) | Executive Vice President & Chief Operating Officer | 1,281 | $286.14 | $366,545 |
| Bio-Rad Laboratories, Inc. (BIO-B) | Executive Vice President & Chief Operating Officer | 1,281 | $287.55 | $368,352 |
What does Bio-Rad Laboratories, Inc. do?
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. In addition, the company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
What does Bio-Rad Laboratories, Inc. do?
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. In addition, the company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Andrew J. Last insider trading
Bio-Rad Laboratories, Inc.
Dr. Andrew J. Last has made only one insider trade between 2020-2023, according to the Form 4 filled with the SEC.
As of 29 Apr 2023 he still owns at least 1,281 units of BIO stock.
Bio-Rad Laboratories, Inc.
Dr. Andrew J. Last has made only one insider trade between 2020-2022, according to the Form 4 filled with the SEC.
As of 29 Apr 2023 he still owns at least 1,281 units of BIO-B stock.
Bio-Rad Laboratories key executives
Bio-Rad Laboratories, Inc. executives and other stock owners filed with the SEC:
- Dr. Andrew J. Last (65) Executive Vice President & Chief Operating Officer
- Mr. Ilan Daskal (59) Executive Vice President & Chief Financial Officer
- Mr. Norman D. Schwartz (75) Chairman, Chief Executive Officer & Pres
- Ms. Dara Grantham Wright (49) Executive Vice President & Pres of Clinical Diagnostics Group